About: IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 1998

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 1998 (uk) im August 1998 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'agostu de 1998 (ast) scientific article published on 01 August 1998 (en)
publication date	wds:Q77115285-A42F4B49-10D8-41BD-8B7E-4A308A081AAD
publication date	1998-08-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q77115285-E11A304F-EB68-4590-8892-B69FBD5089EE
cites work	Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies
author name string	wds:Q77115285-1F12C215-AFEC-4700-8A4D-CD649755EBCA wds:Q77115285-328E184A-F639-4338-81BA-D52E6B693433 wds:Q77115285-45EA77A2-3661-4A3E-AAB2-121D69FF290B wds:Q77115285-4BF2BC3A-21A8-43A0-9D05-856DD3B2D446 wds:Q77115285-546384E3-EFDC-40D3-8E62-68A96BB169D8 wds:Q77115285-6C6B680E-8944-41E0-BEC6-E67581235FA2 wds:Q77115285-6F829EA4-1DF2-4184-88A9-2EDE1451A4B1 wds:Q77115285-C8C91E85-6F4F-4724-BA06-59C46171B715 wds:Q77115285-CCAD44D2-2131-45EB-B9FE-2A4C3EC931DE
author name string	F Galbiati G Comi G Martino L Moiola E Brambilla A Vincent L Adorini L M Grimaldi S Amadio
rdfs:label	IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease (en) IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease (nl)
skos:prefLabel	IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease (en) IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease (nl)
name	IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease (en) IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease (nl)
title	wds:Q77115285-FF330A0B-1DB0-47E3-893F-27403FD7AAB6
title	IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease (en)
page(s)	wds:Q77115285-E33A55D2-D14D-410B-A16B-06DFDABC17EE
page(s)	2487-2497
instance of	wds:Q77115285-3B6EA247-2FA0-44C5-BD87-C962C0BE7F12
instance of	scholarly article
main subject	wds:Q77115285-AEF49D47-8D9E-4232-A59A-3E565FCCACB0
main subject	myasthenia gravis
PubMed ID	wds:Q77115285-895DB337-F413-4552-AF7C-1906712024B3
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9710226
PubMed ID	9710226
published in	wds:Q77115285-0EC320D4-0477-4645-A8CA-099F90104F3F
published in	European Journal of Immunology
issue	wds:Q77115285-49E25CA8-61E8-4F75-92A0-6AA19F6D5361
volume	wds:Q77115285-A30A1592-1B5A-49C6-8722-517F5B9B2B2C
issue	8
volume	28
DOI	wds:Q77115285-D0B7D625-1241-4217-81DE-CA2EF50EAF10
DOI	http://dx.doi.org/10.1002/(SICI)1521-4141(199808)28:08%3C2487::AID-IMMU2487%3E3.0.CO;2-Y
DOI	10.1002/(SICI)1521-4141(199808)28:08<2487::AID-IMMU2487>3.0.CO;2-Y
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q77115285
is cites work of	C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells Tumor necrosis factor receptor p55 and p75 deficiency protects mice from developing experimental autoimmune myasthenia gravis Anti-IL-12 antibody prevents the development and progression of multiple sclerosis-like relapsing--remitting demyelinating disease in NOD mice induced with myelin oligodendrocyte glycoprotein peptide Acetylcholine receptor-reactive antibody induces nitric oxide production by a rat skeletal muscle cell line: influence of cytokine environment IL-4 receptor as a bridge between the immune system and muscle in experimental myasthenia gravis I: up-regulation of muscle IL-15 by IL-4 Natural killer cells determine the outcome of B cell–mediated autoimmunity Protective molecular mimicry in experimental myasthenia gravis Mechanism of nasal tolerance induced by a recombinant fragment of acetylcholine receptor for treatment of experimental myasthenia gravis Oral administration of an immunodominant T-cell epitope downregulates Th1/Th2 cytokines and prevents experimental myasthenia gravis Myocytes respond in vivo to an antibody reactive with the acetylcholine receptor by upregulating interleukin-15: an interferon-gamma activator with the potential to influence the severity and course of experimental myasthenia gravis T Cells and Cytokines in the Pathogenesis of Acquired Myasthenia Gravis BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDO. The molecular anatomy of human Hsp60 and its similarity with that of bacterial orthologs and acetylcholine receptor reveal a potential pathogenetic role of anti-chaperonin immunity in myasthenia gravis The immunopathogenesis of myasthenia gravis Helper T cells in antibody-mediated, organ-specific autoimmunity Interleukin-4 deficiency facilitates development of experimental myasthenia gravis and precludes its prevention by nasal administration of CD4+ epitope sequences of the acetylcholine receptor Suppression of experimental autoimmune myasthenia gravis in IL-10 gene-disrupted mice is associated with reduced B cells and serum cytotoxicity on mouse cell line expressing AChR. Interleukin-12 enhances clinical experimental autoimmune myasthenia gravis in susceptible but not resistant mice Prevention of autoimmune attack by targeting specific T-cell receptors in a severe combined immunodeficiency mouse model of myasthenia gravis. B-cell-activating factor and autoimmune myasthenia gravis Is pathogenic humoral autoimmunity a Th1 response? Lessons from (for) myasthenia gravis Clonal expansions of CD4+ B helper T cells in autoimmune myasthenia gravis Autoantibodies to IL-12 in myasthenia gravis patients with thymoma; effects on the IFN-gamma responses of healthy CD4+ T cells LF 15-0195 prevents from the development and inhibits the progression of rat experimental autoimmune myasthenia gravis Adoptive protection from experimental myasthenia gravis with T cells from mice treated nasally with acetylcholine receptor epitopes Cytokine-based immunointervention in the treatment of autoimmune diseases Intercommunication between the neuroendocrine and immune systems: focus on myasthenia gravis. Decreased expression of Src homology 2 domain-containing protein tyrosine phosphatase 1 reduces T cell activation threshold but not the severity of experimental autoimmune myasthenia gravis A Natural Variant of the Signaling Molecule Vav1 Enhances Susceptibility to Myasthenia Gravis and Influences the T Cell Receptor Repertoire Myocyte production of nitric oxide in response to AChR-reactive antibodies in two inbred rat strains may influence disease outcome in experimental myasthenia gravis Is pathogenic humoral autoimmunity a Th1 response? Reply to saoudi et al
is cites work of	wds:Q37849489-5C0010D9-59B5-42CE-9E9B-463641D9F8F3 wds:Q52915933-4C4AF3F0-D4B7-411C-9BA2-A20D23801932 wds:Q63363347-B7EBA557-A534-4710-ADBA-45FFDFF9C16C wds:Q79833067-0BB7E1C0-D412-416E-A4D4-98276D3B31AB wds:Q33901936-056B6359-5C73-43FB-80A5-DB932CB27B9C wds:Q40179681-3BEA00E5-4C47-4098-8E49-1FDC05E3E664 wds:Q37218062-2CAC1B26-4267-47E2-9DB8-8418776597C6 wds:Q40844250-943EF057-7FB1-4F7B-9055-9F5091B01323 wds:Q44088405-0C1FBC02-A2E1-4631-9482-4B6CDEB3C44A wds:Q44639078-29BDC8C6-A099-4A51-A484-D60855BB96CE wds:Q73784387-273AB0DA-9391-46C4-B8CD-05CBCF8E0F53 wds:Q51770946-4E47B39B-4008-4A82-9079-AD5E7F945BCC wds:Q43845628-F755B451-82A4-43F4-8870-63C4B0D9F4E5

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software